Investors in GlaxoSmithKline plc (NYSE: GSK) saw new options begin trading today, for the August 2017 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 242 days until expiration the newly trading contracts represent a
Investors in GlaxoSmithKline plc (NYSE: GSK) saw new options begin trading today, for the August 2017 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 242 days until expiration the newly trading contracts represent a
Share this Article
Recommended